#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arginase deficiency Carcinoid syndrome Mitochondrial DNA depletion Dupuytren's contracture Congenital leptin deficiency Depression Autoimmune disorder Desmoplastic small round cell tumour Noonan syndrome Autoimmune myositis Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Angiosarcoma non-metastatic SAPHO syndrome Multifocal motor neuropathy Malignant melanoma More trials…

    Learn about Rare Diseases

    Haemophilia – Diagnostics Richter’s syndrome – Life with Disease Chondrosarcoma – Trials in Disease Waldenstrom’s macroglobulinaemia recurrent Myxofibrosarcoma – Basic Information Thrombotic thrombocytopenic purpura – Life with Disease Marfan’s syndrome – Life with Disease Usher’s syndrome – Basic Information Haemophilia A with anti factor VIII – Diagnostics Pulmonary fibrosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Enalapril Maleate Vinblastine Sulfate Indacaterol Acetate Nacystelyn Metformin Ecoo6A Lolium Perenne Pollen Extract Benzylpenicillin Sodium Cyanocobalamin LUNRESERTIB Tozorakimab Levoleucovorin Thiotepa Crofelemer Navtemadlin Rebisufligene Etisparvovec Pentosan Polysulfate Sodium Iph5201 VOXVOGANAN Pemetrexed Disodium More therapies…

    Learn about Your Condition

    Brain stem glioma Triple negative breast cancer Nephroblastoma Cervix carcinoma stage III Pyrexia Skin bacterial infection Subarachnoid haemorrhage Colorectal cancer stage III Arteriospasm coronary Hypocalcaemia Dementia Alzheimer's type Juvenile spondyloarthritis Ichthyosis Ischaemic skin ulcer Bladder cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Asthma

  • Testing WIN378 Safety and Effects in Adults with Moderate or Severe Asthma

    Recruiting

    2 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • HUMAN IGG1 MONOCLONAL ANTIBODY AGAINST TSLP
    Bulgaria France Germany Spain Sweden

  • Tezepelumab Effects on TSLP Protein Induction in Adults with Severe Asthma, With and Without Chronic Rhinosinusitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Tezepelumab
    Denmark

  • Safety and Tolerability of Benralizumab in Patients with HES, EGPA, or Asthma Who Completed a Prior Study

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Benralizumab
    Austria Belgium Denmark France Italy The Netherlands +1

  • Evaluating Gradual Interval Extension of Tezepelumab in Drug Combination for Patients with Severe Asthma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Mepolizumab
    • Benralizumab
    • Tezepelumab
    The Netherlands

  • Efficacy and safety of indacaterol acetate (combined with glycopyrronium bromide and mometasone furoate) versus salmeterol/fluticasone in adolescents with asthma

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Indacaterol Acetate
    • Salmeterol
    • Fluticasone Propionate
    France Germany Hungary Poland Romania Slovakia +1

  • Asthma in adults: beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide compared with beclometasone dipropionate and formoterol fumarate dihydrate

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Beclometasone Dipropionate
    • Beclometasone Dipropionate Anhydrous
    • Formoterol Fumarate Dihydrate
    Bulgaria France Germany Italy Poland Romania +2
Previous Page
1 … 3 4 5 6 7 … 14
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!